Literature DB >> 12642047

Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.

L Gaffikin1, P D Blumenthal, M Emerson, K Limpaphayom.   

Abstract

BACKGROUND: To increase screening and treatment coverage, innovative approaches to cervical-cancer prevention are being investigated in rural Thailand. We assessed the value of a single-visit approach combining visual inspection of the cervix with acetic acid wash (VIA) and cryotherapy.
METHODS: 12 trained nurses provided services in mobile (village health centre-based) and static (hospital-based) teams in four districts of Roi-et Province, Thailand. Over 7 months, 5999 women were tested by VIA. If they tested positive, after counselling about the benefits, potential risks, and probable side-effects they were offered cryotherapy. Data measuring safety, acceptability, feasibility, and effort to implement the programme were gathered.
FINDINGS: The VIA test-positive rate was 13.3% (798/5999), and 98.5% (609/618) of those eligible accepted immediate treatment. Overall, 756 women received cryotherapy, 629 (83.2%) of whom returned for their first follow-up visit. No major complications were recorded, and 33 (4.4%) of those treated returned for a perceived problem. Only 17 (2.2%) of the treated women needed clinical management other than reassurance about side-effects. Both VIA and cryotherapy were highly acceptable to the patients (over 95% expressed satisfaction with their experience). At their 1-year visit, the squamocolumnar junction was visible to the nurses, and the VIA test-negative rate was 94.3%.
INTERPRETATION: A single-visit approach with VIA and cryotherapy seems to be safe, acceptable, and feasible in rural Thailand, and is a potentially efficient method of cervical-cancer prevention in such settings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642047     DOI: 10.1016/s0140-6736(03)12707-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  72 in total

1.  Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya.

Authors:  Hillary Mabeya; Kareem Khozaim; Tao Liu; Omenge Orango; David Chumba; Latha Pisharodi; Jane Carter; Susan Cu-Uvin
Journal:  J Low Genit Tract Dis       Date:  2012-04       Impact factor: 1.925

2.  A comparison of triage methods for Kenyan women who screen positive for cervical intraepithelial neoplasia by visual inspection of the cervix with acetic acid.

Authors:  K C L Lewis; V D Tsu; A Dawa; N A Kidula; I N Chami; J W Sellors
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

3.  Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Authors:  Naiyana Praditsitthikorn; Yot Teerawattananon; Sripen Tantivess; Supon Limwattananon; Arthorn Riewpaiboon; Saibua Chichareon; Nantakan Ieumwananonthachai; Viroj Tangcharoensathien
Journal:  Pharmacoeconomics       Date:  2011-09       Impact factor: 4.981

4.  Report on a cryotherapy service for women with cervical intraepithelial neoplasia in a district hospital in western Kenya.

Authors:  K D C Lewis; J W Sellors; A Dawa; V D Tsu; N A Kidula
Journal:  Afr Health Sci       Date:  2011-09       Impact factor: 0.927

5.  Alliance for cervical cancer prevention: setting the record straight.

Authors:  Jacqueline Sherris; Thomas C Wright; Lynette Denny; Rengaswamy Sankaranarayanan; Amy E Pollack; Harshad Sanghvi; John W Sellors
Journal:  Am J Public Health       Date:  2006-12-28       Impact factor: 9.308

6.  Trying to resolve a dispute over the best way to diagnose cervical neoplasia in a developing country.

Authors:  Lynne Gaffikin; Harshad Sanghvi; Ricky Lu; Paul D Blumenthal
Journal:  Medscape J Med       Date:  2008-01-10

7.  Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam.

Authors:  Proma Paul; Jennifer L Winkler; Rosario M Bartolini; Mary E Penny; Trinh Thu Huong; Le Thi Nga; Edward Kumakech; Emmanuel Mugisha; Jose Jeronimo
Journal:  Oncologist       Date:  2013-11-11

Review 8.  Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.

Authors:  Eric Chamot; Sibylle Kristensen; Jeffrey S A Stringer; Mulindi H Mwanahamuntu
Journal:  BMC Womens Health       Date:  2010-04-01       Impact factor: 2.809

9.  Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, India.

Authors:  Patti E Gravitt; Proma Paul; Hormuzd A Katki; Haripriya Vendantham; Gayatri Ramakrishna; Mrudula Sudula; Basany Kalpana; Brigitte M Ronnett; K Vijayaraghavan; Keerti V Shah
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

10.  Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.

Authors:  Rebecca B Perkins; Sarah M Langrish; Linda J Stern; James F Burgess; Carol J Simon
Journal:  Womens Health Issues       Date:  2009-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.